These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 9663668)
1. Loss of heterozygosity on chromosome 2q: possibly a poor prognostic factor in head and neck cancer. Ransom DT; Barnett TC; Bot J; de Boer B; Metcalf C; Davidson JA; Turbett GR Head Neck; 1998 Aug; 20(5):404-10. PubMed ID: 9663668 [TBL] [Abstract][Full Text] [Related]
2. Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma. el-Naggar AK; Hurr K; Batsakis JG; Luna MA; Goepfert H; Huff V Cancer Res; 1995 Jun; 55(12):2656-9. PubMed ID: 7780981 [TBL] [Abstract][Full Text] [Related]
3. Allelic loss on chromosomes 2q, 3p and 21q: possibly a poor prognostic factor in oral squamous cell carcinoma. Yamamoto N; Mizoe Je; Numasawa H; Tsujii H; Shibahara T; Noma H Oral Oncol; 2003 Dec; 39(8):796-805. PubMed ID: 13679203 [TBL] [Abstract][Full Text] [Related]
4. Fractional allele loss indicates distinct genetic populations in the development of squamous cell carcinoma of the head and neck (SCCHN). Nunn J; Scholes AG; Liloglou T; Nagini S; Jones AS; Vaughan ED; Gosney JR; Rogers S; Fear S; Field JK Carcinogenesis; 1999 Dec; 20(12):2219-28. PubMed ID: 10590212 [TBL] [Abstract][Full Text] [Related]
5. Allelotype of squamous cell carcinoma of the head and neck: fractional allele loss correlates with survival. Field JK; Kiaris H; Risk JM; Tsiriyotis C; Adamson R; Zoumpourlis V; Rowley H; Taylor K; Whittaker J; Howard P Br J Cancer; 1995 Nov; 72(5):1180-8. PubMed ID: 7577465 [TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity (LOH) on chromosomes 2q, 3p and 21q in Indian oral squamous cell carcinoma. Yamamoto N; Kuroiwa T; Katakura A; Shibahara T; Choudhury C Bull Tokyo Dent Coll; 2007 Aug; 48(3):109-17. PubMed ID: 18057857 [TBL] [Abstract][Full Text] [Related]
7. Impact of chromosome 14q loss on survival in primary head and neck squamous cell carcinoma. Lee DJ; Koch WM; Yoo G; Lango M; Reed A; Califano J; Brennan JA; Westra WH; Zahurak M; Sidransky D Clin Cancer Res; 1997 Apr; 3(4):501-5. PubMed ID: 9815712 [TBL] [Abstract][Full Text] [Related]
8. Chromosome 22q a frequent site of allele loss in head and neck carcinoma. Poli-Frederico RC; Bergamo NA; Reis PP; Kowalski LP; Zielenska M; Squire JA; Rogatto SR Head Neck; 2000 Sep; 22(6):585-90. PubMed ID: 10941160 [TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity at 9p and p53 immunopositivity in surgical margins predict local relapse in head and neck squamous cell carcinoma. Graveland AP; Golusinski PJ; Buijze M; Douma R; Sons N; Kuik DJ; Bloemena E; Leemans CR; Brakenhoff RH; Braakhuis BJ Int J Cancer; 2011 Apr; 128(8):1852-9. PubMed ID: 20568113 [TBL] [Abstract][Full Text] [Related]
10. Microsatellite analysis and response to chemotherapy in head-and-neck squamous-cell carcinoma. Blons H; Cabelguenne A; Carnot F; Laccourreye O; de Waziers I; Hamelin R; Brasnu D; Beaune P; Laurent-Puig P Int J Cancer; 1999 Aug; 84(4):410-5. PubMed ID: 10404095 [TBL] [Abstract][Full Text] [Related]
11. [Loss of heterozygosity of 3p21 and 9p21 in head and neck squamous cell carcinomas and its prognostic implication]. Matsuura K; Shiga K; Yokoyama J; Tateda M; Nakano H; Saijo S; Takasaka T Nihon Jibiinkoka Gakkai Kaiho; 1999 May; 102(5):613-21. PubMed ID: 10388315 [TBL] [Abstract][Full Text] [Related]
12. An allelotype of squamous carcinoma of the head and neck using microsatellite markers. Ah-See KW; Cooke TG; Pickford IR; Soutar D; Balmain A Cancer Res; 1994 Apr; 54(7):1617-21. PubMed ID: 8137268 [TBL] [Abstract][Full Text] [Related]
13. Allelic loss at chromosomes 3p, 8p, 13q, and 17p associated with poor prognosis in head and neck cancer. Li X; Lee NK; Ye YW; Waber PG; Schweitzer C; Cheng QC; Nisen PD J Natl Cancer Inst; 1994 Oct; 86(20):1524-9. PubMed ID: 7932807 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of allelic imbalances on chromosome 9p in stage I non-small cell lung carcinoma. Tomizawa Y; Adachi J; Kohno T; Hamada K; Saito R; Noguchi M; Matsuno Y; Hirohashi S; Yamaguchi N; Yokota J Clin Cancer Res; 1999 May; 5(5):1139-46. PubMed ID: 10353749 [TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity on chromosomes 2p, 3p, 18q21.3 and 11p15.5 as a poor prognostic factor in stage II and III (FIGO) cervical cancer treated by radiotherapy. Kozlowski L; Filipowski T; Rucinska M; Pepinski W; Janica J; Skawronska M; Poznanski J; Wojtukiewicz MZ Neoplasma; 2006; 53(5):440-3. PubMed ID: 17013540 [TBL] [Abstract][Full Text] [Related]
16. Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. van der Riet P; Nawroz H; Hruban RH; Corio R; Tokino K; Koch W; Sidransky D Cancer Res; 1994 Mar; 54(5):1156-8. PubMed ID: 8118798 [TBL] [Abstract][Full Text] [Related]
17. Sequential loss of heterozygosity in the progression of squamous cell carcinoma of the lung. Endo C; Sagawa M; Sato M; Chen Y; Sakurada A; Aikawa H; Takahashi S; Usuda K; Saito Y; Fujimura S Br J Cancer; 1998 Sep; 78(5):612-5. PubMed ID: 9744500 [TBL] [Abstract][Full Text] [Related]
18. Sarcomatoid carcinoma of the head and neck: molecular evidence for evolution and progression from conventional squamous cell carcinomas. Choi HR; Sturgis EM; Rosenthal DI; Luna MA; Batsakis JG; El-Naggar AK Am J Surg Pathol; 2003 Sep; 27(9):1216-20. PubMed ID: 12960805 [TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity studies in squamous cell carcinomas of the head and neck. Ransom DT; Leonard JH; Kearsley JH; Turbett GR; Heel K; Sosars V; Hayward NK; Bishop JF Head Neck; 1996; 18(3):248-53. PubMed ID: 8860766 [TBL] [Abstract][Full Text] [Related]